The Comprehensive Clinical & Commercial Dossier
40-Page Institutional-Grade Technical Monograph Backing Clinical Claims
A rigorous, publication-grade 40-page technical monograph deconstructing the formulation's active pharmacodynamics, mechanism of action, transdermal flux modeling, and physiological claim substantiation. Designed to withstand peer review by physicians, institutional investors, and regulatory evaluators.
• 40-Page Bound & Digital Investor-Grade Technical Dossier
• Pharmacokinetic & Pharmacodynamic Literature Audits
• Competitive Mechanism-of-Action (MoA) Deconstruction Matrix
• Evidence-Based Claim Substantiation Data Sheets
R 28,000 (Baseline rate)
Doctor-dispensed skincare lines, pharmaceutical spin-offs, and institutional investment funding rounds.
Prevents unsubstantiated clinical claims; accelerates private institutional funding and medical/dermatological endorsements.